Immunohistochemistry and transmission electron microscopy were used to clarify the cellular origin for plutonium-239-induced pulmonary proliferative (preneoplastic) epithelial lesions and epithelial neoplasms in F344 rats. Examples of each histologic type of proliferative lesion and neoplasm were stained by the avidin-biotin complex immunoperoxidase method using antibodies to rat surfactant apoprotein and Clara cell antigen. Rat surfactant apoprotein immunostaining was detected in type I1 pneumocytes in sections of normal lung, in the cells of the proliferative lesions classified histologically as alveolar epithelial hyperplasia ( 5 1) and mixed foci (alveolar epithelial hyperplasia with fibrosis) (30), and in adenomas (2), adenocarcinomas (3), and adenosquamous carcinomas (2). With the exception of one adenosquamous carcinoma, Clara cell antigen immunostaining was not detected in any of the pulmonary lesions but was detected in nonciliated cuboidal epithelial (Clara) cells in normal bronchioles. The epithelial cells of the proliferative lesions and neoplasms had ultrastructural features consistent with type I1 pneumocytes, i.e., the presence of cytoplasmic lamellar and multivesicular bodies. The results of these studies indicate that the majority of plutonium-induced proliferative epithelial lesions and neoplasms in the rat originate from alveolar type I1 pneumocytes.
Inhaled plutonium induces pulmonary carcinomas in rats and other laboratory rodents under a variety of exposure c o n d i t i o n~.~~~~~~J~ Morphologically, the neoplasms are generally similar to those that develop spontaneously in the lungs of humans and laboratory rodents and to those that are induced in laboratory rodents by a variety of carcinogens. 18, 20 The cellular origin for these neoplasms has not been established. Based on data obtained by light microscopy, electron microscopy, and immunohistochemistry, the alveolar type I1 p n e u m~c y t e~.~.~~.~~.~~ and/or the bronchiolar Clara ce1111J3J4J6,2' are potential cells of origin.
Accurate identification of the cell(s) of origin for radiation-induced pulmonary neoplasms would allow a better estimation of the doses necessary to induce radiation damage and neoplastic transformation in I Present addresses: Chemical Carcinogenesis Branch, National Institute of Environmental Health Sciences, Research Triangle Park, NC (RAH); Poisonous Plant Research, 1 150 East 1400 North, Logan, UT (BSS); and Genentech Inc., South San Francisco, CA (NAG). plutonium; rats; type I1 pneumocytes; ultrastructure. these cells. Ultimately, risk for lung cancer could be determined in terms of radiation dose to the most sensitive cells. For regulatory purposes, determining the dose to cells at risk rather than using average dose to the lung may be a more desirable method for determining safety standards for human exposure.
Recent results suggest that rats develop pulmonary epithelial neoplasms through a progression of focal hyperplastic, metaplastic, and dysplastic epithelial lung lesions after the inhalation of aerosols of plutonium-239 dioxide (239Pu02).9 The lesions developed primarily in subpleural and peribronchiolar regions of the lungs, preceding the development of the neoplasms, and were considered to be preneoplastic. Histologically, the proliferative lesions were classified as alveolar epithelial hyperplasia, fibrosis, fibrosis with squamous metaplasia, mixed (fibrosis with alveolar epithelial hyperplasia), and bronchiolar-alveolar metaplasia. Pulmonary adenomas, adenocarcinomas, squamous cell carcinomas, and adenosquamous carcinomas were the epithelial neoplasms observed; adenocarcinomas and squamous cell carcinomas were most prevalent.
Observations made by light microscopy, morphometry, and cytokinetics suggest that the proliferative lesions of alveolar epithelial hyperplasia are the precursor lesions from which adenocarcinomas develop. Foci of fibrosis in which squamous metaplasia develop appear to be the precursor lesions for the squamous cell carcinomas. Data obtained by morphometric evaluation of the proliferative lesions established that the volume and epithelial surface densities of the foci of alveolar epithelial hyperplasia increased with time after exposure, in contrast to the other proliferative lesions, which did not progressively increase. Thus, foci of alveolar epithelial hyperplasia are more likely to progress to malignant neoplasms than are the other morphologic types of proliferative lesions identified.
The light microscopic examination of the lesions was not conclusive in determining the cellular origin of the pulmonary lesions. However, the location of the lesions in the alveolar region of the lungs suggests an origin from type I1 pneumocytes. Type I1 pneumocytes and Clara cells in the normal lung and in a variety of nonneoplastic and neoplastic pulmonary lesions have been identified by immunohistochemical methods using antibodies specific for these cell types. 12.13,19,2~26,28,29,31, 32 Transmission electron microscopy has often provided additional useful information but taken alone has not always been conclusive. In the present study, we combined immunohistochemistry and transmission electron microscopy with our previous light microscopic findings to clarify the cellular origin of plutonium-induced proliferative epithelial lesions and neoplasms in the lungs of rats.
Materials and Methods

Animals
Female F344/N rats, 13 & 2 weeks old, were obtained from the breeding colony of the Inhalation Toxicology Research Institute and randomized by litter and body weight for assignment to the study. Three rats per polycarbonate cage were housed in the Institute's barrier facility, in rooms maintained at 72 f 3 F (22.2 k 1.6 C) with 50 * 10% relative humidity, and a 12-hour photoperiod (6:OO a.m. to 6:OO p.m.) cycle. Feed (Lab Blox, Allied Mills, Chicago, IL) and fresh water were provided ad libitum. Based on serologic analysis, the rats were certified free of serum antibodies to Mycoplasma sp. and to all known pneumotropic viruses.
Exposures
The rats were exposed per nasum to aerosols of 239Pu02 to establish initial lung burdens (ILB) of 3.7 kBq. The aerosols were prepared from suspensions of 239Pu(IV) hydroxide in 0.6 mol/liter HCI (2.5 mg/ml) with a Ytterbium-169 (i69Yb) marker. The aerosols were nebulized, dried, and oxidized in a two-staged heat treatment at 300 F (1 48.8 C) and 1 150 F (62 1.1 C), mixed with clean air, and passed into a 96-p0rt, nose-only exposure chamber in which 90 rats were loaded. The exposure duration was approximately 50 minutes. The activity median aerodynamic diameter and geometric standard deviation of the aerosols were 1.24 k 0.10 pm and 1.6 1 +. 0.03 pm, respectively. After exposure, the 169Yb was counted externally to determine ILB, retention of 239Pu02 in the lung, and radiation dose to the lung. The ILB were estimated for each rat by whole-body counting to quantify the i69Yb at 0, 4, 7, 14, 30, 60, 120, 240, and 360 days after exposure. The mean ILB of 239Pu02 deposited was 3.2 +-0.9 kBq per rat. This ILB would result in a dose to lung of 16 Gy at 500 days after e x p o~u r e .~
Euthanasia and tissue processing
Groups of rats were euthanatized on days 7, 30, and 90 and subsequently at 3-month intervals to 450 days after exposure. The rats were anesthetized with 4% halothane and exsanguinated by cardiac puncture. The trachea and lungs were removed en bloc from the thoracic cavity. The left lung lobe from each rat was isolated and expanded to inspiratory volume by intratracheal instillation of 10% neutral buffered formalin (NBF) at a constant pressure of 25 cm H,O for 6 hours. The lobes were fixed by immersion in NBF overnight then placed in 70% alcohol. Cross-sectional 4-mm-thick slices of the left lobe were embedded in paraffin, sectioned at 5 pm, and stained with hematoxylin and eosin for light microscopic classification of the lesions.
Immunohistochemistr y
Immunoreactivity of type I1 pneumocytes and Clara cells was determined using unstained 5-pm sections of the paraffin-embedded left lung lobes that contained representative proliferative and neoplastic lesions previously identified by light microscopic examination. A rabbit polyclonal antibody to rat surfactant apoprotein (RSAP) and a mouse monoclonal antibody to rat Clara cell 10-kd protein (RtCC 10) were used to detect type I1 pneumocytes and Clara cells, respectively, in the lesions. The preparation, characterization, and specificities of both antisera have been described in detail.i2.i3.24-29 Tissue culture supernatant of the hybridoma producing anti-RtCC 10 was precipitated with a 40% solution of ammonium sulfate, and the precipitate was dialyzed in 0.05% Tris (pH 7.6)-buffered 0.15 M NaCI. Immunohistochemical evaluation was performed using an avidin-biotin complex (ABC) immunoperoxidase procedure3J0 and Vectastain ABC kits (Vector Laboratories, Burlingame, CA). The RSAP and RtCClO antibodies were diluted I : 200 and 1 : 5, respectively, with 0.5 M Tris-buffered saline solution. The sections were treated with the chromogen 3,3'-diaminobenzidine tetrachloride to visualize immunoreactive cells in the pulmonary lesions then counterstained with hematoxylin. As negative controls, lung sections were treated with normal rabbit and mouse sera at similar concentrations. Type I1 pneumocytes in the histologically normal alveolar epithelium surrounding the lesions and Clara cells in the terminal bronchioles served as in situ positive controls within the pulmonary lesions for assessment of the sensitivity and specificity of the staining reaction. 
Transmission electron microscopy
One-millimeter-square blocks of the pulmonary neoplasms identified by light microscopic examination and blocks of randomly selected grossly visible proliferative lesions were excised and fixed in Karnovsky's solution overnight. The blocks were postfixed in 1 Yo osmium tetroxide in cacodylate buffer for 1 hour, dehydrated through a graded series of alcohols, and embedded in epoxy resin. Thick sections were prepared, stained with toluidine blue, and selected by light microscopic examination for subsequent electron microscopic examination. Thin sections of the selected tissues were mounted on copper grids and stained with uranyl acetate and lead citrate.
Results
Immunohistochemical findings
The application of rabbit anti-rat RSAP and mouse anti-rat RtCC 10 to sections of normal rat lung selec- tively immunostained normal rat type I1 pneumocytes ( Fig. 1 ) and bronchiolar Clara cells (Fig. 2) , respectively, in both the control and exposed rats. Immunoreactive cells had a distinctive golden brown to brown cytoplasmic staining. The staining reaction was typically of moderate to strong intensity, granular, and diffuse within the cytoplasm. Weak background staining of the alveolar septa and connective tissue components of the lung was sometimes detected with RSAP antibody. Variable RSAP immunostaining was detected in the cytoplasm of alveolar macrophages and on the ciliated surface of the bronchiolar epithelial cells. Immunoreactive type I1 pneumocytes in the normal alveolar parenchyma were usually located at the junctions of the alveolar septa. The RtCClO antibody was highly specific for Clara cells; neither the alveolar and ciliated bronchiolar epithelial cells nor the interstitial tissues were immunoreactive. Fig. 3 . Lung; rat exposed to 239Pu02. Focus of alveolar epithelial hyperplasia demonstrates positive immunoreactivity for surfactant apoprotein. Antibody dilution 1 : 200. Fig. 4 . Lung; rat exposed to 239Pu02. In this focus of bronchiolar-alveolar metaplasia immunostained for surfactant apoprotein, immunoreactivity is confined to layer of cilia. Antibody dilution 1 : 200. Lung; rat exposed to 239Pu02. Positive immunoreactivity is evident in an adenosquamous carcinoma immunostained for surfactant apoprotein. Antibody dilution 1 : 200. Fig. 8 . Lung; rat exposed to 239Pu02. Positive immunoreactivity is evident in an adenosquamous carcinoma immunostained for Clara cell antigen. Antibody dilution 1 : 5. The results of the immunohistochemical staining among the various histologic types of pulmonary proliferative lesions and neoplasms identified in the lungs of the exposed rats are summarized in Table 1 . Among the proliferative lesions, the cells of the foci of alveolar epithelial hyperplasia were consistently immunoreactive with the RSAP antibodies (Fig. 3) . The hyperplastic epithelial cells of the mixed lesions also had positive immunostaining with RSAP antibodies. In contrast, none of the proliferative lesions had positive RtCClO immunostaining. The character of the cytoplasmic staining reaction was similar to that of normal reactive type I1 pneumocytes and was generally diffuse within the lesions. However, the intensity of the staining reaction in positive cells varied from moderate to strongly intense among the lesions and to a lesser extent among individual cells within the lesions. Some of the more advanced hyperplastic alveolar epithelial lesions had focal areas in which RSAP immunostaining was weak or absent.
Immunostaining was not detected with either of the antibodies in the foci of fibrosis or bronchiolar-alveolar metaplasia. However, RSAP immunostaining was detected on the surfaces of the ciliated cells in the foci of bronchiolar alveolar metaplasia (Fig. 4) . Macrophages that were frequently present within the proliferative lesions had weakly to strongly positive cytoplasmic RSAP reactivity, possibly due to phagocytosed surfactant. Mast cells were also frequently observed in the proliferative lesions and invariably immunostained intensely with either of the antibodies (Fig. 4) . The cytoplasmic granules of mast cells have a strong binding affinity for avidin and, therefore, consistently have nonspecific immun~reactivity.~ With the exception of the squamous cell carcinomas, positive RSAP immunostaining was detected in most of the plutonium-induced pulmonary neoplasms evaluated ( Table 1) . In contrast, RtCC 10 immunostaining was detected in only one neoplasm, an adenosquamous carcinoma. The RSAP immunoreactivity within the adenomas was generally similar to that of the focal lesions of alveolar epithelial hyperplasia. The majority of the cuboidal cells comprising these neoplasms showed moderate to intense staining, generally distributed diffusely within the cytoplasm (Fig. 5) . The RSAP staining reaction of the adenocarcinomas varied. Some adenocarcinomas had almost diffuse immunoreactivity of moderate to strong intensity confined to the neoplastic cells in irregular acinar formations within the neoplasms (Fig. 6) . Focally, there were areas of the neoplasms in which immunostaining of the neoplastic cells was weak or absent. In other adenocarcinomas, the immunoreactive cells occurred in scattered groups and focally within the acinar formations. Of the two adenosquamous carcinomas evaluated, one had positive RSAP immunostaining and no RtCC 10 immunostaining and the other had positive RtCC 10 immunostaining and inconclusive RSAP immunoreactivity. Positively stained cells in both neoplasms were confined to the adenocarcinomatous portion of the neoplasms. The staining reaction of the RSAP-positive neoplasm was diffuse and moderately intense (Fig. 7) . The immunoreactive cells within the RtCC 1 O-positive neoplasm were sparsely scattered and occurred individually, in small groups, and focally in irregular glandular formations within the neoplasm (Fig.  8) .
Ultrastructural findings
Ultrastructurally, most of the proliferative pulmonary lesions and neoplasms contained cells with characteristics consistent with type I1 pneumocytes, namely the presence of cytoplasmic lamellar bodies and cytoplasmic multivesicular bodies. Ultrastructural characteristics consistent with Clara cells, such as electron-dense secretory granules and abundant agranular endoplasmic reticulum, were not observed in any of the pulmonary lesions.
Among the proliferative lesions, lamellar bodies were most readily detected in the cells of focal alveolar epithelial hyperplasia. The cells were cuboidal or low columnar with large, irregular nuclei that had prominent nucleoli. Lamellar bodies, varying in size and number, were consistently present within the cytoplasm ( Fig. 9 ). Occasionally, multivesicular bodies, another ultrastructural feature of type I1 pneumocytes, were observed near or fused to the lamellar bodies. Short microvilli, also characteristic of type I1 pneu- mocytes, lined the alveolar surface of the cells (Fig.  10) . Lamellar bodies were occasionally noted in the ciliated cells of the foci of bronchiolar-alveolar metaplasia ( Fig. l l) .
The ultrastructural features of the pulmonary neoplasms were also consistent with differentiation from type I1 pneumocytes. The cells of the adenomas were round to polygonal with short microvilli on the alveolar surfaces (similar to Fig. 10 ). Most had oval nuclei with indentations of the nuclear membrane. Mature cytoplasmic lamellar bodies, usually well developed, were easily identified. Rare cytoplasmic multivesicular bodies were also observed. The adenocarcinomas were composed of large polygonal cells with pleomorphic nuclei having clumped, marginated chromatin (Fig. 12) . Many nuclei were cleaved and/or had irregularly indented nuclear membranes. The neoplastic cells had a variable number of mature cytoplasmic lamellar bodies and short microvilli on their free luminal surfaces. Cytoplasmic lamellar bodies were also observed in the neoplastic epithelial cells of the adenocarcinomatous portion of the adenosquamous carcinoma.
The neoplastic cells of the squamous cell carcinoma had ultrastructural features typical of squamous cells with bundles of tonofilaments circumferentially arranged around the nucleus and extensive cell mem- Fig. 11 . Lung; rat exposed to 239Pu0,. Focus of bronchiolar-alveolar metaplasia. Note cytoplasmic lamellar bodies (arrows) and cilia. Uranyl acetate/lead citrate. Bar = 0.85 w. Fig. 13 . Lung; rat exposed to 23yPu0,. Squamous cell carcinoma. Uranyl acetate/lead citrate. Bar = 1.4 Mm. Vet Pathol 31:3, 1994 brane interdigitation joined by desmosomes (Fig. 13) . The presence of a few lamellar bodies in the cytoplasm of occasional cells, however, suggested a type I1 pneumocyte origin.
Discussion
The histogenesis of spontaneously occurring and carcinogen-induced pulmonary preneoplastic and neoplastic lesions in the lungs of laboratory rodents has been controversial. On the basis of findings by light and electron microscopy, several investigators have reported that these lesions are derived from the nonciliated bronchiolar epithelial (Clara) cells in rats,17s23 mice,14 and Syrian hamsters.16.21 Others have implicated the alveolar type I1 pneumocyte as the cell of origin in ratsls-20 and mice. 22 The present study of 239Pu02-induced proliferative and neoplastic pulmonary lesions has provided immunohistochemical and ultrastructural evidence that, in rats, most of these lesions arise from type I1 pneumocytes. The major evidence to support this contention was the detection of RSAP immunoreactivity and not RtCClO immunoreactivity in a significant number of the proliferative lesions and neoplasms. RSAP immunoreactivity was detected in the proliferative lesions classified as alveolar epithelial hyperplasia and as mixed foci but was absent from the fibrotic and metaplastic lesions. RSAP was detected in all pulmonary neoplasms except the squamous cell carcinomas. RtCC 10 was not detected in any 239Pu02-induced proliferative preneoplastic lesions but was detected focally in one neoplasm, an adenosquamous carcinoma. The presence of RtCC 10 and RSAP immunoreactivity in normal Clara cells and type I1 pneumocytes in the same lung sections with immunonegative proliferative and neoplastic lesions was proof that these lesions lacked detectable immunoreactivity.
There are no published comparable immunohistochemical studies of radiation-induced pulmonary lesions. However, the results of similar immunohistochemical studies of spontaneously occurring and chemically induced proliferative and neoplastic lesions in the lungs of rats and mice are comparable. In rats, RSAP was detected in normal type I1 pneumocytes and in the majority of the cells in spontaneously occurring and N-nitrosomethylurea (NMU)-induced focal alveolar hyperplasia.ls In the same study, adenomas in hyperplastic lesions, adenomas, and carcinomas also had RSAP immunoreactivity. Cells immunoreactive for RtCClO were detected only focally in one experimentally induced adenoma and in four naturally occurring adenomas. In separate experiments, RSAP but not RtCC 10 immunoreactivity was detected in the pulmonary proliferative and neoplastic lesions of mice injected with N-nitrosodiethylamineZ1 and NMU. 33 In humans,' RSAP immunoreactivity has been demonstrated in some peripheral pulmonary neoplasms, suggesting that some of these neoplasms also arise from type I1 p n e u m o~y t e s .~~
The results from similar experiments with Syrian hamsters are, however, conflicting. Hamsters injected with N-nitrosodiethylamine developed many foci of bronchiolar-alveolar hyperplasia composed of both ciliated and nonciliated cells. 21 The cells in most of the focal hyperplasias and in 50% of the pulmonary neoplasms observed were immunoreactive for Clara cell protein.
In this study, the detection of focal RtCClO immunoreactivity in one of the pulmonary neoplasms, an adenosquamous carcinoma, is not surprising. Embryologically, type I1 pneumocytes and Clara cells are derived from the same stem cell. 1~1 9 , 3 1 . 3 2 Surfactant apoprotein and Clara cell antigenicity can be demonstrated in pulmonary cells early in fetal lung development. 12. 19.24,26,29 In the dedifferentiated neoplastic state, some neoplastic cells may begin to express Clara cell antigens. An alternative explanation is that the focal RtCClO immunoreactivity may represent Clara cells trapped within neoplasms of type I1 pneumocyte origin. However, this scenario is unlikely because some of the RtCC 10 immunoreactive cells were detected in discrete glandular formations.
The ultrastructural characteristics of the alveolar epithelial hyperplasia, adenomas, and adenocarcinomas supported the immunohistochemical findings, providing additional evidence for their origin from type I1 pneumocytes. Most significant was the frequent finding of cytoplasmic lamellar bodies in the cells comprising these lesions. In the lungs, lamellar bodies are unique to type I1 pneumocytes and are the most frequent and reliable ultrastructural markers used to identify type I1 pneumocyte~.',~,~~ Lamellar bodies are the sites of production and storage of the pulmonary surfactant. In rodent species, the presence of cytoplasmic lamellar bodies is a relatively reliable ultrastructural characteristic frequently used to differentiate neoplasms of type I1 pneumocyte origin from those of Clara cell rigi in.^,^^ In this study, the number of lamellar bodies varied among the pulmonary lesions but appeared to be more numerous in the cells of alveolar epithelial hyperplasia and less numerous in the cells of metaplastic lesions and the pulmonary neoplasms. Variation in the stages of differentiation among the cells of these lesions may explain this finding.
Occasionally, cytoplasmic multivesicular bodies were found in cells of some of the lesions. Multivesicular bodies are considered to be another, although less specific, ultrastructural characteristic of type I1 pneumoc y t e~. '~ The multivesicular bodies are found in varying abundance and are thought to be involved in the for-mation of lamellar bodies and the recirculation of pulmonary s~r f a c t a n t .~~
The immunohistochemical analyses did not provide conclusive evidence for the cellular origin of the proliferative lesions of either bronchiolar-alveolar metaplasia or the squamous cell carcinomas. This lack of immunoreactivity may be explained in two ways. The lesions may be derived from cell types in the periphery of the lungs other than type 11 pneumocytes or Clara cells. Alternatively, the lesions may have actually originated from either type I1 pneumocytes or Clara cells but may have lost their specific antigenicity concomitant with differentiation to another cell type. Ultrastructurally, some cells in these lesions contained cytoplasmic inclusions morphologically consistent with lamellar bodies, suggesting an origin from type I1 cells. However, these lamellar inclusions did not appear to be as well differentiated as those present in the alveolar epithelial hyperplasia, and their numbers were considerably lower.
In rats, the majority of 239Pu0,-induced pulmonary proliferative lesions and neoplasms are derived from type I1 pneumocytes, as indicated by 1) the finding of RSAP rather than RtCC 10 immunoreactivity in the majority of the proliferative lesions and neoplasms and 2) the presence of ultrastructural markers specific for type I1 pneumocytes (lamellar bodies) in the cells of the lesions. 
